third rock ventures close congratulations to kala pharmaceuticals on its m initial public offering read more third rock launches tango therapeutics with m series a to develop novel medicines designed to target cancer vulnerabilities read more third rock announces sarah larson as partner read more third rock launches goldfinch bio with m series a to develop precision therapies for kidney disease read more partner abbie celniker named among boston business journals  innovation allstars read more congratulations to voyager therapeutics on being named one of the boston globes  top places to work read more third rock launches magenta therapeutics with m to apply new stem cell science to reboot the immune system read more allergan to acquire motus therapeutics read more third rock ventures raises  million oversubscribed fund read more partner profile charles homcy read more eleven biotherapeutics acquires viventia bio to create targeted protein therapeutics oncology company read more congratulations to our fierce  winners rhythm fulcrum and neon read more third rock launches relay therapeutics with m to build the world’s first dedicated drug discovery platform centered on protein motion read more take a look at what we’ve been up to for the past  years watch the video sign up for weekly portfolio company news alerts here  read more andrew stricos who has huntington’s disease and his wife tell their story at a luncheon hosted by third rock watch the video transforming healthcare  portfolio companies with more than  billion under management  clinical studies underway within our portfolio  diseases being targeted by our companies    of thousands patients impacted by portfolio company products and clinical trials ×   andrew stricos who has huntington’s disease and his wife tell their story at a luncheon hosted by third rock ×   partner charles homcy shares the story of founding myokardia close copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy portfolio third rock ventures portfolio our portfolio companies share a common goal – a fearless approach to addressing unmet medical needs through bold ideas and transformative science filter by all companies private public acquired cancer cardiovascular disease gastrointestinal infectious diseases metabolic disorders neurologicpsychiatric diseases ophthalmology hearing disorders rare genetic  orphan diseases renal respiratory urology devicetherapeutic technology diagnostic gene therapy personalized medicine technology platform biologics small molecules east coast companies west coast companies all companies copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy our people third rock ventures people we are a bicoastal multidisciplinary team that brings together the best of science strategy business and medicine partners alexis borisy partner abbie celniker phd partner neil exter partner kevin gillis partnerchief financial officer charles homcy md partner sarah larson partnerchief human resources officer mark levin partner craig muir partnerchief technology officer cary pfeffer md partner kevin starr partner robert tepper md partner venture partners frank t gentile phd venture partner mark a goldsmith md phd venture partner perry karsen venture partner christoph lengauer phd venture partner philip reilly md jd venture partner stephen sherwin md venture partner jeffrey tong phd venture partner barbara weber md venture partner entrepreneursinresidence jason coloma phd entrepreneurinresidence keith dionne entrepreneurinresidence jeffrey finer md phd entrepreneurinresidence brian jones phd entrepreneurinresidence robert kamen phd entrepreneurinresidence leon murphy phd entrepreneurinresidence glenn pierce md phd entrepreneurinresidence laurence turka md entrepreneurinresidence domain experts karina chmielewski senior director platform operations dina ciarimboli general counsel cynthia clayton head of communications john keilty general manager platform operations principals and associates brian albrecht phd principal tim funnell dphil principal melissa mccracken phd associate travis murdoch md principal vyas ramanan phd associate dominique verhelle phd mba principal finance  accounting alison connors cpa controller scott frechette cpa staff accountant ivan hyep senior finance manager greg mcgraw accounting manager jessica schoenig cpa staff accountant recruiting andrea dimella recruiting director tracy nicholson recruiting director chris robinson vice president recruiting administrative zoe angell executive assistant megan graziano manager of operations and administration linda heath executive assistant marcia hemphill office manager  west coast and executive assistant rhea kappa receptionistadministrative assistant laura vitale administrative assistant maribel laboy executive assistant ian miller administrative assistant corey o’keeffe event planner  communications angelo severino executive assistant tracy williams executive assistant at third rock people are our most valuable asset check our careers page to learn about career opportunities within the third rock portfolio third rock careers copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy third rock ventures ii lp private company information  bloomberg july    pm et capital markets company overview of third rock ventures ii lp snapshot people company overview third rock ventures ii lp specializes in early stage investments the fund seeks to invest in medical and life sciences companies  newbury streetrd floorboston ma united statesfounded in  phone  fax  key executives for third rock ventures ii lp mr mark j levin cofounder and partner age  mr kevin p starr cofounder and partner age  dr robert i tepper md partner and cofounder age  mr alexis borisy am partner age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact third rock ventures ii lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close secgems third rock ventures gp ii lp data feeds now available excel  csv  java  python etc database learn more third rock ventures gp ii lp info ownership filings  third rock ventures  newbury street rd floor boston  ma   usa  filing datecurrent and former nameschanged on date third rock ventures gp ii lp central index key cik  state of incorporation de country of incorporation usa fiscal year end  ownership form  filings levin mark j   starr kevin p   tepper robert i   trv gp ii llc   trv gp iii llc   third rock ventures gp iii lp   third rock ventures ii lp   third rock ventures iii lp   all related personscompanies filings blueprint medicines corp   global blood therapeutics inc   jounce therapeutics inc   levin mark j   myokardia inc   starr kevin p   sage therapeutics inc   tepper robert i   trv gp ii llc   trv gp iii llc   third rock ventures gp iii lp   third rock ventures ii lp   third rock ventures iii lp   db insider trading  third rock ventures ii lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  third rock ventures ii lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm global blood therapeutics inc gbt third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert istarr kevin p owner    direct view sale  pm sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana global blood therapeutics inc gbt third rock ventures ii lpstarr kevin pthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana global blood therapeutics inc gbt third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert istarr kevin p owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana global blood therapeutics inc gbt third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view conversion  pm nana global blood therapeutics inc gbt third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view other  pm nana sage therapeutics inc sage third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jtepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana blueprint medicines corp bpmc third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llclevin mark jstarr kevin ptepper robert i owner   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  our investment strategy third rock ventures philosophy we build great companies in order to make a dramatic difference for patients our investment strategy discover launch build our mission  core values our investment strategy we discover launch and build great companies based on bold ideas that meet at the intersection of science strategy business and medicine  where transformational science meets operational reality  providing the best opportunity to make a dramatic difference in patients lives the third rock team our team has a proven record of translating disruptive technologies into valuable business enterprises we adhere to a “third rock forever” philosophy realizing that we have been phenomenally successful because of the contributions of the whole third rock team people are our greatest asset and we invest significant effort and resources to ensure we hire the best people at third rock and across the portfolio working closely with leading scientific and business visionaries as well as industry partners our team is focused on identifying opportunities to change the future of medicine and rigorously vets those ideas through our discovery process to develop the vision strategy and plan needed to succeed learn about our people  download third rock team fact sheet a formula for innovation we only invest in the best of those ideas we are actively involved in the early stages of our companies development typically serving as members of the founding management teams to build a strong foundation put in place the right people and culture and set the companies on a path to scientific and operational excellence view our portfolio  download third rock company fact sheet then we build on that foundation transitioning out of our interim leadership roles as we put in place rock star management teams we bring to bear the vast experience expertise and network of our team and across our portfolio to help our companies succeed management teams can tap into our network of experts across disciplines including science medicine business healthcare economics and regulatory strategy our partner development team leverages our relationships with decisionmakers in pharma to support business development efforts across our portfolio our strategy team serves as an advisory resource around critical business development financial and operational decisions our beyond great leadership program provides our portfolio leaders with a peertopeer network as well as tools and resources focused on shared elements of building transformational companies we build great companies together with our portfolio leaders scientific founders advisors and industry partners we try never to forget that medicine is for the people it is not for the profits the profits follow and if we have remembered that they have never failed to appear the better we have remembered it the larger they have been copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy contact third rock ventures contact submit interesting disruptive ideas here boston third rock ventures llc  newbury street rd floor boston ma  phone   fax   san francisco third rock ventures llc  mission bay blvd south suite  san francisco ca  phone   fax   copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy media center third rock ventures media center   sign up for weekly portfolio company news alerts here download center third rock brochure third rock company profile third rock team profile news archives third rock news  events january    third rock ventures names sarah larson as partner» read more october    third rock ventures raises  million fund iv» read more september    third rock ventures’ venture partner phil reilly to receive the henri termeer lifetime achievement award at the th annual tribute to champions of hope» read more may    third rock ventures’ venture partner phil reilly to speak at massbio event to discuss his new book “orphan the quest to save children with rare disease”» read more april    third rock ventures partner robert tepper to moderate panel at the world medical innovation forum» read more april    third rock ventures partner cary pfeffer to present at xconomys exome whats hot in boston biotech » read more portfolio news agios pharmaceuticals july    agios to webcast conference call of second quarter  financial results on august   » press release  company news allena pharmaceuticals july    european commission grants orphan drug designation to allena pharmaceuticals investigational therapy for the treatment of primary hyperoxaluria » press release  company news blueprint medicines july    blueprint medicines to evaluate opportunities to advance rare disease discovery program in fibrodysplasia ossificans progressiva following discontinuation of collaboration with alexion » press release  company news cytomx therapeutics july    cytomx therapeutics to announce second quarter  financial results and provide midyear update » press release  company news blueprint medicines july    blueprint medicines to report second quarter  financial results on wednesday august   » press release  company news global blood therapeutics july    global blood therapeutics announces new employment inducement grants » press release  company news kala pharmaceuticals july    kala pharmaceuticals announces close of initial public offering and exercise of underwriters’ option » press release  company news neon therapeutics july    neon therapeutics and apexigen announce immunooncology clinical trial collaboration » press release  company news relay therapeutics july    relay therapeutics names deborah palestrant phd vice president of corporate development and strategy » press release  company news kala pharmaceuticals july    kala pharmaceuticals announces pricing of initial public offering » press release  company news news archives copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy third rock ventures ii lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active third rock ventures ii lp • boston ma • venture capital fund how do i update this listing third rock ventures ii is based out of boston whalewisdom has at least  dg filings in our database for third rock ventures ii the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from third rock ventures ii lp enter your email address below and choose submit your email cancel contact info third rock ventures ii lp  newbury street boston ma     business phone  sec sic codepharmaceutical preparations recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on  sc ga filed on  sc ga filed on  sc ga filed on  sc ga filed on  current dg holdings stock sector shares held market value rank source source date blueprint medicines corp bpmc health care    g  sage therapeutic sage health care    g  myokardia inc myok health care    g  global blood therapeutics inc gbt health care    g  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  d pooled investment fund venture capital fund pooled investment fund interests    other issuers in filings name address no other issuers related parties included in filings name address relationship kevin starr subscription required executive officer mark levin subscription required executive officer na third rock ventures gp ii lp subscription required executive officer na trv gp ii llc subscription required executive officer robert tepper subscription required executive officer elevate your investments try it for free third rock ventures llc  financial services firm boston massachusetts  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthird rock ventures llc third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees share third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description third rock ventures llc is a ria based in boston ma information type ria head quarters boston ma  of employees none total assets na website location  newbury st boston ma   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets third rock ventures gp ii lp   third rock ventures gp iii lp   third rock ventures gp iv lp   third rock ventures gp lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership kevin paul starr effective officer december  less than  robert ira tepper effective officer december  less than  mark jay levin effective officer december  less than  kevin michael gillis chief finanacial officer april  less than  alexis borisy effective officer september  less than  abbie celniker effective officer september  less than  source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations third rock ventures secures m for fund ii  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital third rock ventures secures m for fund ii september   by pehub administrator print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub third rock ventures secures m for fund ii third rock ventures llc has raised  million for a second fund earmarked for life sciences companies the firm which raised a debut fund of  million back in  also announced several personnel changes including the promotion of alexis borisy from entrepreneurinresidence to partner continue reading on pe hub writes third rock ventures llc has raised  million for a second fund earmarked for life sciences companies the firm which raised a debut fund of  million back in  also announced several personnel changes including the promotion of alexis borisy from entrepreneurinresidence to partner press release third rock ventures llc a venture capital firm focused on building life sciences companies today announced the final closing of fund ii raising  million in an oversubscribed fund with fund ii third rock will continue to execute on its strategy and build on its successful track record of launching and supporting transformative life sciences companies “we are grateful for the strong support for our model and the significant interest from our existing and new investors” said kevin starr partner of third rock ventures “in  we founded third rock with a  million fund i which enabled us to successfully seed support or launch more than life sciences companies these companies were formed around disruptive areas of science and medicine and many were developed as part of third rock’s unique company discovery process we look forward to continuing to partner with entrepreneurs researchers and company founders to pursue bold ideas and groundbreaking science that promise to dramatically improve the lives of patients” new additions to the third rock team third rock is announcing several changes and additions to the team these include the promotion of alexis borisy from entrepreneurinresidence eir to partner at third rock the addition of charles homcy md formerly chief executive officer of portola pharmaceuticals as venture partner leading the newly established west coast office and the addition of david armistead phd formerly chief scientific officer of cgi pharmaceuticals – now gilead and chris varma formerly with flagship ventures as eirs as recently announced nick leschly formerly a partner with third rock ventures has assumed the role of president and ceo of portfolio company bluebird bio robert tepper md third rock ventures partner stated “we are delighted to bring added breadth and depth to our team with senior capabilities in commercial rd drug discovery and product development these new hires add critical mass to our team and extend the guidance and support we can provide to our portfolio companies” third rock opens san francisco office third rock is establishing an office in san francisco to better enable the firm to work directly with its growing portfolio of west coastbased companies third rock partner craig muir and principal jake bauer are relocating to san francisco where they will work closely with dr homcy as well as the bostonbased team “our approach has always been to closely engage and collaborate with experts academic centers and entrepreneurs and the west coast office enables us to extend our reach and maintain this model” stated mark levin partner of third rock ventures “i am personally very excited to work with charles again in leading rd efforts and launching new companies with craig and jake from our boston office joining charles in san francisco this team will seamlessly integrate across third rock to collaborate with entrepreneurs to build launch and operate our portfolio companies” about third rock ventures third rock ventures is a venture firm focused on life sciences investing and launching companies that make a difference in people’s lives collaborating with entrepreneurs the third rock team applies its deep expertise to establish the roadmap and building blocks for a rapidly growing and highly successful life sciences company the third rock team has a unique vision and experience in building great companies extensive academic and industry networks and a collective track record for creatively managing the value creation path to deliver exceptional performance for more information please visit the firm’s website at wwwthirdrockventurescom current third rock portfolio companies ablexis afferent pharmaceuticals agios pharmaceuticals alnara pharmaceuticals bluebird bio constellation pharmaceuticals dc devices edimer pharmaceuticals eleven biotherapeutics foundation medicine nine point medical seventh sense biosystems and zafgen pure communications inc sheryl seapy  print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub third rock ventures secures m for fund ii third rock ventures llc has raised  million for a second fund earmarked for life sciences companies the firm which raised a debut fund of  million back in  also announced several personnel changes including the promotion of alexis borisy from entrepreneurinresidence to partner continue reading on pe hub writes find new deal opportunities supercharge your fundraising efforts and track top managers with vcj get your free trial or subscribe now dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy the carveout curveball by pehublogger network raymond james expands team with new hire by iris dorbian blackstone acquires clarion events from providence by iris dorbian form  global blood therapeutic for jun  filed by third rock ventures ii lp research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  global blood therapeutic for jun  filed by third rock ventures ii lp by k wizard—  pm et  httparchivefastedgarcomaczdzcsjjzzzzswgizzrz filed on june   more gbt news global blood therapeutics announces participation at the goldman sachs th annual global healthcare conference globenewswire   pm et  research reports coverage on biotech stocks  editas medicine global blood therapeutics geron and infinity pharma pr newswire   am et  global blood therapeutics announces upcoming presentation of gbt data in adolescents with sickle cell disease at european hematology association’s nd congress globenewswire   pm et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  third rock ventures llc  financial services firm boston massachusetts  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthird rock ventures llc third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees share third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description third rock ventures llc is a ria based in boston ma information type ria head quarters boston ma  of employees none total assets na website location  newbury st boston ma   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets third rock ventures gp ii lp   third rock ventures gp iii lp   third rock ventures gp iv lp   third rock ventures gp lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership kevin paul starr effective officer december  less than  robert ira tepper effective officer december  less than  mark jay levin effective officer december  less than  kevin michael gillis chief finanacial officer april  less than  alexis borisy effective officer september  less than  abbie celniker effective officer september  less than  source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations career opportunities third rock ventures careers overview opportunities beyond great opportunities industries all jobs cancer cardiovascular disease gastrointestinal infectious diseases metabolic disorders neurologicpsychiatric diseases ophthalmology rare genetic  orphan diseases renal respiratory urology devicetherapeutic technology diagnostic gene therapy personalized medicine technology platform biologics small molecules functions all functions business development clinical research data science engineering hardware engineering qa engineering software it and informatics manufacturing operations project and program management rd regulatory affairs research sciassocmgr sales technicalcustomer support process engineer drug product  newton ma us senior systems engineer and security specialist  cambridge ma us animal technician invivo immunooncology  cambridge ma us senior scientist – computational chemistry  cambridge ma us senior desktop and lab support engineer  cambridge ma us scientist  senior scientist pharmacology  cambridge ma us biomarker researcher  cambridge ma us clinical scientist  cambridge ma us clinical trial manager  cambridge ma us medical director  cambridge ma us development project management  cambridge ma us senior scientist  cambridge ma us vice president of biology  cambridge ma us research associatesenior research associate vitro pharmacology  boston ma us associate director pharmacology  cambridge ma us associate directordirector  business development  cambridge ma us electrical test engineer  san francisco ca us firmware test engineer  san francisco ca us electrical engineering technician  san francisco ca us clinical affairs manager  san francisco ca us senior assembler  san francisco ca us application verification engineer  san francisco ca us dsp engineer  san francisco ca us director of service operations  san francisco ca us senior backend engineer  san francisco ca us senior analog design engineer  san francisco ca us senior ios engineer  san francisco ca us lead clinical trial manager  cambridge ma us lead cmc analytical development  cambridge ma us senior manager regulatory affairs  cambridge ma us manager clinical informatics  cambridge ma us research associate in vivo pharmacology  cambridge ma us scientistsr scientist in vivo pharmacology  cambridge ma us scientist vaccine immunologist  cambridge ma us senior scientist analytical chemistry  cambridge ma us scientist t cell immunology  cambridge ma us research associate  associate scientist biochemistry protein expression and purification  cambridge ma us bioinformatics engineer  cambridge ma us senior scientist peptide chemistry  cambridge ma us head of immunology  cambridge ma us associate scientistscientist i analytical chemistry  cambridge ma us clinical data manager  cambridge ma us senior clinical research associate  bedford ma us territory manager sales  united states of america senior scientist dna encoded chemistry library discovery  san francisco ca us research associate  senior research associate discovery biology  san francisco ca us scientist i medicinal chemistry  san francisco ca us research associate – cell biology phenotypic and high throughput screening  redwood city ca us associate directordirector dmpk  redwood city ca us scientistssr scientists biology  redwood city ca us scientistsenior scientist medicinal chemistry  redwood city ca us sr research associate medicinal chemistry  redwood city ca us senior research associate cell biology phenotypic and high throughput screening  redwood city ca us scientist ii medicinal chemistry  redwood city ca us director cmc  redwood city ca us senior scientist iiassociate director safety pharmacology and toxicology  redwood city ca us senior scientist medicinal chemistry  redwood city ca us senior project manager  associate director project management  redwood city ca us copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy career opportunities third rock ventures careers overview opportunities beyond great opportunities industries all jobs cancer cardiovascular disease gastrointestinal infectious diseases metabolic disorders neurologicpsychiatric diseases ophthalmology rare genetic  orphan diseases renal respiratory urology devicetherapeutic technology diagnostic gene therapy personalized medicine technology platform biologics small molecules functions all functions business development clinical research data science engineering hardware engineering qa engineering software it and informatics manufacturing operations project and program management rd regulatory affairs research sciassocmgr sales technicalcustomer support process engineer drug product  newton ma us senior systems engineer and security specialist  cambridge ma us animal technician invivo immunooncology  cambridge ma us senior scientist – computational chemistry  cambridge ma us senior desktop and lab support engineer  cambridge ma us scientist  senior scientist pharmacology  cambridge ma us biomarker researcher  cambridge ma us clinical scientist  cambridge ma us clinical trial manager  cambridge ma us medical director  cambridge ma us development project management  cambridge ma us senior scientist  cambridge ma us vice president of biology  cambridge ma us research associatesenior research associate vitro pharmacology  boston ma us associate director pharmacology  cambridge ma us associate directordirector  business development  cambridge ma us electrical test engineer  san francisco ca us firmware test engineer  san francisco ca us electrical engineering technician  san francisco ca us clinical affairs manager  san francisco ca us senior assembler  san francisco ca us application verification engineer  san francisco ca us dsp engineer  san francisco ca us director of service operations  san francisco ca us senior backend engineer  san francisco ca us senior analog design engineer  san francisco ca us senior ios engineer  san francisco ca us lead clinical trial manager  cambridge ma us lead cmc analytical development  cambridge ma us senior manager regulatory affairs  cambridge ma us manager clinical informatics  cambridge ma us research associate in vivo pharmacology  cambridge ma us scientistsr scientist in vivo pharmacology  cambridge ma us scientist vaccine immunologist  cambridge ma us senior scientist analytical chemistry  cambridge ma us scientist t cell immunology  cambridge ma us research associate  associate scientist biochemistry protein expression and purification  cambridge ma us bioinformatics engineer  cambridge ma us senior scientist peptide chemistry  cambridge ma us head of immunology  cambridge ma us associate scientistscientist i analytical chemistry  cambridge ma us clinical data manager  cambridge ma us senior clinical research associate  bedford ma us territory manager sales  united states of america senior scientist dna encoded chemistry library discovery  san francisco ca us research associate  senior research associate discovery biology  san francisco ca us scientist i medicinal chemistry  san francisco ca us research associate – cell biology phenotypic and high throughput screening  redwood city ca us associate directordirector dmpk  redwood city ca us scientistssr scientists biology  redwood city ca us scientistsenior scientist medicinal chemistry  redwood city ca us sr research associate medicinal chemistry  redwood city ca us senior research associate cell biology phenotypic and high throughput screening  redwood city ca us scientist ii medicinal chemistry  redwood city ca us director cmc  redwood city ca us senior scientist iiassociate director safety pharmacology and toxicology  redwood city ca us senior scientist medicinal chemistry  redwood city ca us senior project manager  associate director project management  redwood city ca us copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy